bi 1839100
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 23, 2022 (NCT05354453)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06572111 | Phase 1 | Sep 24, 2024 | Boehringer Ingelheim |
| NCT06360094 | Phase 2 | Aug 20, 2024 | Boehringer Ingelheim |
| NCT05934955 | Phase 1 | Jul 13, 2023 | Boehringer Ingelheim |
| NCT05738291 | Phase 1 | Apr 26, 2023 | Boehringer Ingelheim |
| NCT05354453 | Phase 1 | May 23, 2022 | Boehringer Ingelheim |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 5 | 5 | 2 | 2022 |
1 organizations
Page 1 / 1